Burleson & Co’s Avantis US Equity ETF AVUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$129K Buy
1,897
+1,655
+684% +$113K 0.03% 143
2022
Q3
$15K Hold
242
﹤0.01% 257
2022
Q2
$16K Buy
242
+1
+0.4% +$71 ﹤0.01% 241
2022
Q1
$19K Buy
241
+1
+0.4% +$76 ﹤0.01% 234
2021
Q4
$19K Buy
240
+1
+0.4% +$78 ﹤0.01% 231
2021
Q3
$18K Sell
239
-1
-0.4% -$75 ﹤0.01% 231
2021
Q2
$18K Sell
240
-35
-13% -$2.55K ﹤0.01% 240
2021
Q1
$19K Buy
+275
New +$18.4K ﹤0.01% 229

Other funds holding AVUS

Burleson & Co's AVUS Position: Q4 2022 in Review

Burleson & Co increased its Avantis US Equity ETF (AVUS) stake by 684% in Q4 2022, buying an estimated $113K and bringing the position to 1,897 shares worth $129K. The position accounts for 0.03% of the portfolio, ranked #143.

Burleson & Co first reported a position in AVUS in Q1 2021 and has held it in 8 quarters since. 216 funds tracked by Wall St. Rank hold AVUS as of Q4 2022.

  • Burleson & Co held 1,897 shares of Avantis US Equity ETF worth $129K as of Q4 2022.
  • Burleson & Co bought 1,655 Avantis US Equity ETF shares in Q4 2022, an estimated $113K.
  • Avantis US Equity ETF made up 0.03% of Burleson & Co's portfolio in Q4 2022, its #143 holding.
  • Burleson & Co first reported a position in Avantis US Equity ETF in Q1 2021 and has held it in 8 quarters since.
  • 216 funds tracked by Wall St. Rank held Avantis US Equity ETF as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.